<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

MHY 553 - NSC 33005

產(chǎn)品貨號

Axon 2814 CAS [6265-56-1] MF C13H9NO2SMW 243.28 Purity: 98% Soluble in DMSO Description MHY 553 is a PPARα agonist that improved aged-induced hepatic steatosis, in part by increasing β-oxidation signaling and decreasing inflammation in the liver. Potential pharmaceutical agent for treating hepatic steatosis in aging. Keywords: MHY 553 | supplier | PPARα agonist? | NSC 33005 | MHY553 | MHY-553 | NSC33005 | NSC-33005 | CAS [6265-56-1] | Metabolism | PPAR | Agonist | Receptors | Hepatic steatosis

產(chǎn)品價格

現(xiàn)貨詢價，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

MHY 553 - NSC 33005

Based on 9 reference(s) in Google Scholar 8 10 9

Axon 2814

CAS [6265-56-1]

MF C13H9NO2S
MW 243.28

Purity: 98%
Soluble in DMSO

MHY 553

Description

MHY 553 is a PPARα agonist that improved aged-induced hepatic steatosis, in part by increasing β-oxidation signaling and decreasing inflammation in the liver. Potential pharmaceutical agent for treating hepatic steatosis in aging.

Keywords: MHY 553 | supplier | PPARα agonist? | NSC 33005 | MHY553 | MHY-553 | NSC33005 | NSC-33005 | CAS [6265-56-1] | Metabolism | PPAR | Agonist | Receptors | Hepatic steatosis?

SM Kim et al. Novel PPARa agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging. Oncotarget. 2017 Jul 11;8(28):46273-46285.

Certificate of Analysis
Material Safety Data Sheet

Diabetes & Metabolism Miscellaneous Pain & Inflammation PPAR NR1C

PPARα agonist

Chemical name

4-(Benzo[d]thiazol-2-yl)benzene-1,3-diol

Parent CAS No.

[6265-56-1]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>